Company Filing History:
3 out of 47 
1 out of 4,674 
1 out of 54,766 
Years Active: 2001-2013
Title: Matthew Marton: Pioneer in Therapeutic Index Determination
Introduction
Matthew Marton is an esteemed inventor based in Seattle, Washington, known for his significant contributions to the medical and scientific fields. With a total of five patents to his name, Marton’s innovations aim to enhance drug specificity and improve therapeutic outcomes for patients. His groundbreaking work has the potential to revolutionize personalized medicine, offering tailored treatment solutions based on individual patient profiles.
Latest Patents
Among Marton's latest patents, the invention titled "Methods for determining therapeutic index from gene expression profiles" stands out. This innovative method provides a way to determine drug specificity, therapeutic index, and effective doses tailored for individual patients. By applying graded levels of a drug to a biological sample or patient, various cellular constituents are measured to assess drug effects on target and off-target pathways. This allows for the identification of therapeutic and toxic concentrations, ultimately aiding in the definition of a therapeutic index—crucial for safe and effective drug administration.
Another notable patent, "Manufacture and use of non-standard size microarray slides," details methods and devices for microarray analysis. This invention addresses the challenge of processing non-standard size slides that contain arrays of chemical compounds. The methodology involves exposing samples to the chemical compounds on the slide’s surface, incubating them, and examining the outcomes of binding reactions. This innovation is vital for enhancing the capabilities of microarray technology in research and diagnostics.
Career Highlights
Throughout his career, Matthew Marton has made significant strides while working at prominent companies, including Rosetta Inpharmatics, Inc. and Agilent Technologies, Inc. His roles at these organizations have allowed him to further develop and refine his inventions, contributing to advancements in the life sciences sector.
Collaborations
In his professional journey, Marton has had the opportunity to collaborate with talented individuals such as Roland Stoughton and Michael Meyer. These interactions have likely fostered innovative thinking and the exchange of ideas that fueled Marton's groundbreaking work.
Conclusion
Matthew Marton's contributions to the fields of medicine and biotechnology are noteworthy, particularly through his innovative approaches to understanding drug specificity and therapeutic dosing. His patents demonstrate a commitment to improving patient care and enhancing the efficacy of treatment options. As the landscape of medical science evolves, Marton’s inventions will likely continue to play a crucial role in shaping future healthcare practices.